ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Novavax, SII File COVID Vax EUA in South Africa
January 10, 2022If authorized, the vaccine will be manufactured by and commercialized by SII in South Africa under the brand name Covovax. -
Hopeful of launching Covovax for adults in October this year, for children in Q1-2022: Serum CEO
August 09, 2021Serum Institute of India CEO Adar Poonawalla said he is hopeful that Covovax will be launched in October, depending on DCGI approvals, for adults and for children by the first quarter of 2022, as reported The Economic Times. -
IMCR and SII collaborate to develop Novavax’s Covid-19 vaccine in India
November 13, 2020Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) have collaborated for clinical development of the Covid-19 vaccine, COVOVAX, by US-based firm Novavax and upscaled by SII.
Pharma Sources Insight January 2025
